- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-4598
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Engineering chimeric antigen receptor-T cells for cancer treatment ; volume:17 ; number:1 ; day:15 ; month:2 ; year:2018 ; pages:1-16 ; date:12.2018
Molecular cancer ; 17, Heft 1 (15.2.2018), 1-16, 12.2018
- Schlagwort
-
Krebs
Onkologie
- Urheber
-
Ye, Baixin
- Beteiligte Personen und Organisationen
-
Stary, Creed M.
Li, Xuejun
Gao, Qingping
Kang, Chunsheng
Xiong, Xiaoxing
SpringerLink (Online service)
- DOI
-
10.1186/s12943-018-0814-0
- URN
-
urn:nbn:de:1111-201804085557
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 10:51 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ye, Baixin
- Stary, Creed M.
- Li, Xuejun
- Gao, Qingping
- Kang, Chunsheng
- Xiong, Xiaoxing
- SpringerLink (Online service)
Ähnliche Objekte (12)
Engineering better chimeric antigen receptor T cells
Chimeric Antigen Receptor T-Cell Therapy
Optimization of chimeric antigen receptor (CAR) therapy
Chimeric antigen receptor–based therapies beyond cancer
Allogeneic Chimeric Antigen Receptor Therapy in Lymphoma
Improving Chimeric Antigen Receptor Design and Therapy for Treatment of Cancer
Antigen-induced chimeric antigen receptor multimerization amplifies on-tumor cytotoxicity
Targeting cardiac fibrosis with chimeric antigen receptor macrophages
Effectors of the Future: Universal Chimeric Antigen Receptor
Multi-antigen-targeted chimeric antigen receptor T cells for cancer therapy
Engineering potent chimeric antigen receptor T cells by programming signaling during T-cell activation
Chimeric antigen receptor natural killer (CAR-NK) cell design and engineering for cancer therapy
Engineering better chimeric antigen receptor T cells
Chimeric Antigen Receptor T-Cell Therapy
Optimization of chimeric antigen receptor (CAR) therapy
Chimeric antigen receptor–based therapies beyond cancer
Allogeneic Chimeric Antigen Receptor Therapy in Lymphoma
Improving Chimeric Antigen Receptor Design and Therapy for Treatment of Cancer
Antigen-induced chimeric antigen receptor multimerization amplifies on-tumor cytotoxicity
Targeting cardiac fibrosis with chimeric antigen receptor macrophages
Effectors of the Future: Universal Chimeric Antigen Receptor
Multi-antigen-targeted chimeric antigen receptor T cells for cancer therapy
Engineering potent chimeric antigen receptor T cells by programming signaling during T-cell activation
Chimeric antigen receptor natural killer (CAR-NK) cell design and engineering for cancer therapy
Engineering better chimeric antigen receptor T cells
Chimeric Antigen Receptor T-Cell Therapy
Optimization of chimeric antigen receptor (CAR) therapy
Chimeric antigen receptor–based therapies beyond cancer
Allogeneic Chimeric Antigen Receptor Therapy in Lymphoma
Improving Chimeric Antigen Receptor Design and Therapy for Treatment of Cancer
Antigen-induced chimeric antigen receptor multimerization amplifies on-tumor cytotoxicity
Targeting cardiac fibrosis with chimeric antigen receptor macrophages
Effectors of the Future: Universal Chimeric Antigen Receptor
Multi-antigen-targeted chimeric antigen receptor T cells for cancer therapy
Engineering potent chimeric antigen receptor T cells by programming signaling during T-cell activation